Literature DB >> 16603356

Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP.

Christopher D Cox1, Maricel Torrent, Michael J Breslin, Brenda J Mariano, David B Whitman, Paul J Coleman, Carolyn A Buser, Eileen S Walsh, Kelly Hamilton, Michael D Schaber, Robert B Lobell, Weikang Tao, Vicki J South, Nancy E Kohl, Youwei Yan, Lawrence C Kuo, Thomayant Prueksaritanont, Donald E Slaughter, Chunze Li, Elizabeth Mahan, Bing Lu, George D Hartman.   

Abstract

Molecular modeling in combination with X-ray crystallographic information was employed to identify a region of the kinesin spindle protein (KSP) binding site not fully utilized by our first generation inhibitors. We discovered that by appending a propylamine substituent at the C5 carbon of a dihydropyrazole core, we could effectively fill this unoccupied region of space and engage in a hydrogen-bonding interaction with the enzyme backbone. This change led to a second generation compound with increased potency, a 400-fold enhancement in aqueous solubility at pH 4, and improved dog pharmacokinetics relative to the first generation compound.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16603356     DOI: 10.1016/j.bmcl.2006.03.040

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

1.  Solution-phase parallel synthesis of a library of delta(2)-pyrazolines.

Authors:  Shankar Manyem; Mukund P Sibi; Gerald H Lushington; Benjamin Neuenswander; Frank Schoenen; Jeffrey Aubé
Journal:  J Comb Chem       Date:  2007 Jan-Feb

2.  Docking studies on kinesin spindle protein inhibitors: an important cooperative 'minor binding pocket' which increases the binding affinity significantly.

Authors:  Cheng Jiang; Yadong Chen; Xiaojian Wang; Qidong You
Journal:  J Mol Model       Date:  2007-06-23       Impact factor: 1.810

3.  Computational fragment-based drug design to explore the hydrophobic sub-pocket of the mitotic kinesin Eg5 allosteric binding site.

Authors:  Ksenia Oguievetskaia; Laetitia Martin-Chanas; Artem Vorotyntsev; Olivia Doppelt-Azeroual; Xavier Brotel; Stewart A Adcock; Alexandre G de Brevern; Francois Delfaud; Fabrice Moriaud
Journal:  J Comput Aided Mol Des       Date:  2009-06-17       Impact factor: 3.686

4.  Cinchona alkaloid catalyzed enantioselective amination of α,β-unsaturated ketones: an asymmetric approach to Δ2-pyrazolines.

Authors:  Nathaniel R Campbell; Bingfeng Sun; Ravi P Singh; Li Deng
Journal:  Adv Synth Catal       Date:  2011-11-01       Impact factor: 5.837

5.  Pathway of ATP hydrolysis by monomeric kinesin Eg5.

Authors:  Jared C Cochran; Troy C Krzysiak; Susan P Gilbert
Journal:  Biochemistry       Date:  2006-10-10       Impact factor: 3.162

6.  3D-QSAR studies of dihydropyrazole and dihydropyrrole derivatives as inhibitors of human mitotic kinesin Eg5 based on molecular docking.

Authors:  Xingyan Luo; Mao Shu; Yuanqiang Wang; Jin Liu; Wenjuan Yang; Zhihua Lin
Journal:  Molecules       Date:  2012-02-17       Impact factor: 4.411

7.  Reactivity of 4-tert-butyldimethylsiloxy-1,2,3,6-tetrahydropyridines with hydrazines.

Authors:  Javier Figueroa; Esther Caballero; Pilar Puebla; Fernando Tomé; Manuel Medarde
Journal:  Molecules       Date:  2006-11-30       Impact factor: 4.411

8.  Brønsted acid-promoted hydroamination of unsaturated hydrazones: access to biologically important 5-arylpyrazolines.

Authors:  Han He; Ning Xu; Honglin Zhang; Bin Chen; Zhengnan Hu; Kang Guo; Jianlin Chun; Shujun Cao; Yingguang Zhu
Journal:  RSC Adv       Date:  2021-05-11       Impact factor: 4.036

9.  Direct catalytic asymmetric synthesis of pyrazolidine derivatives.

Authors:  Luca Deiana; Gui-Ling Zhao; Hans Leijonmarck; Junliang Sun; Christian W Lehmann; Armando Córdova
Journal:  ChemistryOpen       Date:  2012-06-21       Impact factor: 2.911

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.